Phase I clinical trial of a TGF-β antisense-modified tumor cell vaccine in patients with advanced glioma.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 12, p. 1052, doi. 10.1038/sj.cgt.7700975
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2006 AND VI 13 AND IP 12
Results: 7
1
2
Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 12, p. 1045, doi. 10.1038/sj.cgt.7700965
- By:
- Publication type:
- Article
3
Tetracycline-regulated intratumoral expression of interleukin-3 enhances the efficacy of radiation therapy for murine prostate cancer.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 12, p. 1082, doi. 10.1038/sj.cgt.7700977
- By:
- Publication type:
- Article
4
Local gene therapy of solid tumors with GM-CSF and B7-1 eradicates both treated and distal tumors.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 12, p. 1061, doi. 10.1038/sj.cgt.7700976
- By:
- Publication type:
- Article
5
Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 12, p. 1072, doi. 10.1038/sj.cgt.7700981
- By:
- Publication type:
- Article
6
The involvement of nuclear factor-kappa B in cyclooxygenase-2 overexpression in murine colon cancer cells transduced with herpes simplex virus thymidine kinase gene.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 12, p. 1093, doi. 10.1038/sj.cgt.7700983
- By:
- Publication type:
- Article
7
Paclitaxel and vincristine potentiate adenoviral oncolysis that is associated with cell cycle and apoptosis modulation, whereas they differentially affect the viral life cycle in non-small-cell lung cancer cells.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 12, p. 1105, doi. 10.1038/sj.cgt.7700984
- By:
- Publication type:
- Article